UPDATED Sep 10, 2025
Discover large cap Global Healthcare companies from around the world. These Healthcare Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
876 | HK$0.023 | -4.2% | 43.8% | HK$116.0m | n/a | PB0.3x | n/a | n/a | ||
AHI | AU$0.092 | 0% | 15.0% | AU$22.6m | n/a | PE-1.4x | E178.9% | n/a | ||
G3 | RM 0.015 | -25.0% | -40.0% | RM 62.3m | n/a | PS1.3x | n/a | n/a | ||
ASG | CA$0.27 | -1.9% | -3.6% | CA$20.3m | n/a | PB3.8x | n/a | n/a | ||
NSC | د.أ3.03 | 0% | n/a | د.أ10.3m | n/a | PS2.2x | n/a | 1.5% | ||
523696 | ₹68.17 | 0.3% | 15.3% | ₹1.3b | n/a | PE27.7x | n/a | 0% | ||
IZO | CA$0.33 | 0% | 261.1% | CA$20.0m | n/a | PE-6.7x | n/a | n/a | ||
6029 | JP¥206.00 | -2.4% | 52.6% | JP¥2.1b | n/a | PE14.9x | n/a | 0% | ||
POLX | UK£0.0088 | -7.9% | -43.5% | UK£10.6m | n/a | PS4.6x | E38.3% | n/a | ||
ARCOMA | SEK 9.26 | 5.5% | -35.0% | SEK 132.5m | SEK 11.50 | PE20x | E24.4% | n/a | ||
543499 | ₹5.30 | 2.1% | 45.5% | ₹1.2b | n/a | PE227.9x | n/a | n/a | ||
NXL | US$0.81 | -3.5% | -1.0% | US$14.2m | US$4.00 | PS80.8x | E-1.2% | n/a | ||
ALEMG | €4.22 | 0% | -20.1% | €12.0m | €4.00 | PB0.7x | E126.1% | 0% | ||
NVNO | US$0.72 | -7.7% | -86.2% | US$13.8m | n/a | PB0.4x | n/a | n/a | ||
CSOC | US$0.018 | 2.8% | 53.8% | US$13.7m | n/a | n/a | n/a | n/a | ||
IZAFE B | SEK 0.40 | 7.0% | 97.5% | SEK 128.4m | n/a | PS18.8x | n/a | n/a | ||
MEDIC | ₱0.28 | 5.6% | -12.3% | ₱782.8m | n/a | PE6.4x | n/a | 3.3% | ||
8357 | HK$0.17 | 6.3% | 193.1% | HK$106.1m | n/a | PS2.1x | n/a | n/a | ||
CHER | CA$0.96 | -4.0% | n/a | CA$18.8m | n/a | n/a | n/a | n/a | ||
IVF | ฿0.98 | 3.2% | n/a | ฿431.2m | n/a | PS5x | n/a | 2.4% | ||
PHL | NZ$0.43 | -4.4% | -14.0% | NZ$22.7m | n/a | PE3.4x | n/a | n/a | ||
1H3 | S$0.004 | 0% | -55.6% | S$17.2m | n/a | PS1.7x | n/a | n/a | ||
XAIR | US$2.26 | -2.2% | -70.8% | US$13.3m | US$11.20 | PS2.5x | E64.4% | n/a | ||
PFHO | US$1.05 | -6.3% | 28.7% | US$13.2m | n/a | PE9.6x | n/a | n/a |